NOT KNOWN FACTUAL STATEMENTS ABOUT AZ-23

quinupristin/dalfopristin will improve the degree or result of lemborexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Stay away from coadministration of lemborexant with reasonable or powerful CYP3A inhibitors.Antibiotics which include quinupristin and dalfopristin injection will likely not do the job for